Maurice Cassier

780 total citations
49 papers, 332 citations indexed

About

Maurice Cassier is a scholar working on Economics and Econometrics, Management of Technology and Innovation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maurice Cassier has authored 49 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 13 papers in Management of Technology and Innovation and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maurice Cassier's work include Intellectual Property and Patents (13 papers), Biotechnology and Related Fields (12 papers) and Pharmaceutical Economics and Policy (8 papers). Maurice Cassier is often cited by papers focused on Intellectual Property and Patents (13 papers), Biotechnology and Related Fields (12 papers) and Pharmaceutical Economics and Policy (8 papers). Maurice Cassier collaborates with scholars based in France, Niger and Brazil. Maurice Cassier's co-authors include Marilena Corrêa, Christiane Sinding, Jean‐Paul Gaudillière, Dominique Foray, Dominique Stoppa‐Lyonnet, Ilana Löwy, Rosângela Caetano, Dominique Stoppa-Lyonnet, Fanny Chabrol and Soraya Boudia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cadernos de Saúde Pública and Economics of Innovation and New Technology.

In The Last Decade

Maurice Cassier

46 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurice Cassier France 11 97 68 63 47 41 49 332
Arthur Daemmrich United States 10 66 0.7× 15 0.2× 34 0.5× 38 0.8× 17 0.4× 32 297
Jeffrey L. Sturchio United States 9 105 1.1× 60 0.9× 42 0.7× 22 0.5× 91 2.2× 26 328
Aisling McMahon Ireland 8 44 0.5× 33 0.5× 48 0.8× 27 0.6× 5 0.1× 32 195
Stuart Hogarth United Kingdom 12 54 0.6× 42 0.6× 178 2.8× 27 0.6× 8 0.2× 28 563
Irfan Rizvi United States 13 26 0.3× 10 0.1× 17 0.3× 40 0.9× 70 1.7× 22 454
Kishinchand Poornima Wasdani India 8 70 0.7× 69 1.0× 9 0.1× 41 0.9× 27 0.7× 10 245
Fabiana Visentin Netherlands 11 84 0.9× 39 0.6× 49 0.8× 32 0.7× 39 1.0× 22 287
Sudip Chaudhuri India 8 155 1.6× 63 0.9× 55 0.9× 20 0.4× 30 0.7× 19 233
Kevin Dolby United Kingdom 5 36 0.4× 19 0.3× 45 0.7× 15 0.3× 16 0.4× 5 326
Janet Atkinson‐Grosjean Canada 9 80 0.8× 63 0.9× 113 1.8× 39 0.8× 59 1.4× 17 380

Countries citing papers authored by Maurice Cassier

Since Specialization
Citations

This map shows the geographic impact of Maurice Cassier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Cassier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Cassier more than expected).

Fields of papers citing papers by Maurice Cassier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Cassier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Cassier. The network helps show where Maurice Cassier may publish in the future.

Co-authorship network of co-authors of Maurice Cassier

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice Cassier. A scholar is included among the top collaborators of Maurice Cassier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice Cassier. Maurice Cassier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourgain, Catherine, et al.. (2021). Les félicités du capital en santé: Épanouissement, épreuves et tensions critiques des industries pharmaceutiques aux Nords et aux Suds. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
3.
Caetano, Rosângela, et al.. (2021). Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System. Cadernos de Saúde Pública. 37(3). e00277420–e00277420. 25 indexed citations
4.
Cassier, Maurice, et al.. (2018). Health Innovation and Social Justice in Brazil. HAL (Le Centre pour la Communication Scientifique Directe). 12 indexed citations
6.
Cassier, Maurice & Dominique Stoppa-Lyonnet. (2015). La Cour suprême libère les gènes. médecine/sciences. 31(2). 209–213. 1 indexed citations
7.
Cassier, Maurice & Dominique Stoppa-Lyonnet. (2012). Un juge fédéral et le gouvernement des États-Unis interviennent contre la brevetabilité des gènes. médecine/sciences. 28. 11–15. 1 indexed citations
8.
Cassier, Maurice & Dominique Stoppa-Lyonnet. (2011). Un juge fédéral et le gouvernement des États-Unis interviennent contre la brevetabilité des gènes. médecine/sciences. 27(6-7). 662–666. 5 indexed citations
9.
Cassier, Maurice. (2010). FLU EPIDEMICS, KNOWLEDGE SHARING, AND INTELLECTUAL PROPERTY. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
10.
Cassier, Maurice. (2008). Patents and public health in France. Pharmaceutical patent law in‐the‐making at the patent office between the two world wars. History and Technology. 24(2). 135–151. 6 indexed citations
11.
Cassier, Maurice & Christiane Sinding. (2008). ‘Patenting in the public interest:’ administration of insulin patents by the University of Toronto. History and Technology. 24(2). 153–171. 33 indexed citations
12.
Cassier, Maurice. (2008). Producing, Controlling, and Stabilizing Pasteur's Anthrax Vaccine: Creating a New Industry and a Health Market. Science in Context. 21(2). 253–278. 8 indexed citations
14.
Cassier, Maurice. (2007). Délimiter le marché de la santé et faire le droit du vivant. Revue d économie industrielle. 120. 155–174. 3 indexed citations
15.
Cassier, Maurice. (2006). New ‘Enclosures’ and the Creation of New ‘Common Rights’ in the Genome and in Software. Contemporary European History. 15(2). 255–271. 7 indexed citations
16.
17.
Cassier, Maurice & Marilena Corrêa. (2003). Patents, Innovation and Public Health : Brazilian Public-Sector Laboratories'experience in copying AIDS drugs. HAL (Le Centre pour la Communication Scientifique Directe). 89–107. 19 indexed citations
18.
Cassier, Maurice. (2002). Brevets et éthique : les controverses sur la brevetabilité des gènes humains. Revue française des affaires sociales. 235–259. 1 indexed citations
19.
Cassier, Maurice. (2000). Génopoles : quel modèle d'innovation ?. Biofutur. 2000(201). 26–27.
20.
Cassier, Maurice & Dominique Foray. (1999). La régulation de la propriété intellectuelle dans les consortiums de recherche : les types de solutions élaborées par les chercheurs. Économie appliquée. 52(2). 155–182. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026